Jean-Yves Winum

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

Expert opinion on therapeutic patents

Journal of enzyme inhibition and medicinal chemistry

Molecules (Basel, Switzerland)

Chemistry (Weinheim an der Bergstrasse, Germany)

Université de Montpellier

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Montpellier Sep 01 2017

France

Professor :: Chemistry

Université de Montpellier Sep 01 1999 - Aug 31 2017

France

Associate Professor :: Chemistry

Université de Genève Jun 01 1999 - Aug 31 1999

Switzerland

Research associate :: Organic Chemistry

Georgetown University Aug 20 1998 - May 31 1999

United States

Post-doctoral fellow :: Chemistry

Publications

Sébastien Clément, Jean-Yves Winum
Photodynamic therapy alone or in combination to counteract bacterial infections. Expert opinion on therapeutic patents (2024)
Sébastien Clément, Jean-Yves Winum
Photodynamic therapy alone or in combination to counteract bacterial infections. Expert opinion on therapeutic patents 34 (6) (2024)
Sébastien Clément, Jean-Yves Winum
Photodynamic therapy alone or in combination to counteract bacterial infections. Expert opinion on therapeutic patents (2024)
Amina Merabti, Sébastien Richeter, Claudiu T Supuran, Sébastien Clement, Jean-Yves Winum
Are tumor-associated carbonic anhydrases genuine therapeutic targets for photodynamic therapy? Expert opinion on therapeutic targets (2023)
Alessio Nocentini, Alessandro Bonardi, Carla Bazzicalupi, Vincenzo Alterio, Davide Esposito, Simona Maria Monti, Michael Smietana, Giuseppina De Simone, Claudiu T Supuran, Paola Gratteri, Jean-Yves Winum
6-Substituted Triazolyl Benzoxaboroles as Selective Carbonic Anhydrase Inhibitors: In Silico Design, Synthesis, and X-ray Crystallography. Journal of medicinal chemistry (2023)
Muhamad Mustafa, Jean-Yves Winum
The importance of sulfur-containing motifs in drug design and discovery. Expert opinion on drug discovery 17 (5) (2022)
Chiraz Ismail, Alessio Nocentini, Claudiu T Supuran, Jean-Yves Winum, Rafik Gharbi
1,5-Benzodiazepines as a platform for the design of carbonic anhydrase inhibitors. Archiv der Pharmazie (2021)
Emilie Anduran, Ludwig J Dubois, Philippe Lambin, Jean-Yves Winum
Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021. Expert opinion on therapeutic patents (2021)
Emilie Anduran, Ashok Aspatwar, Nanda-Kumar Parvathaneni, Dennis Suylen, Silvia Bua, Alessio Nocentini, Seppo Parkkila, Claudiu T Supuran, Ludwig J Dubois, Philippe Lambin, Jean-Yves Winum
Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation. Molecules (Basel, Switzerland) 25 (10) (2020)
Arnaud Gilles, Léo Frechin, Kundhavai Natchiar, Giulia Biondani, Ottilie von Loeffelholz, Samuel Holvec, Julie-Lisa Malaval, Jean-Yves Winum, Bruno P Klaholz, Jean-François Peyron
Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells 9 (3) (2020)
Annachiara Sarnella, Giuliana D'Avino, Billy Samuel Hill, Vincenzo Alterio, Jean-Yves Winum, Claudiu T Supuran, Giuseppina De Simone, Antonella Zannetti
A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity. International journal of molecular sciences 21 (21) (2020)
Ashok Aspatwar, Nanda Kumar Parvathaneni, Harlan Barker, Emilie Anduran, Claudiu T Supuran, Ludwig J Dubois, Philippe Lambin, Seppo Parkkila, Jean-Yves Winum
Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Andrea Ageli, Fabrizio Carta, Alessio Nocentini, Jean-Yves Winum, Raivis Zalubovskis, Atilla Akdemir, Valentina Onnis, Wagdy M Eldehna, Clemente Capasso, Giuseppina De Simone, Simona Maria Monti, Simone Carradori, William A Donald, Shoukat Dedhar, Claudiu T Supuran
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites 10 (10) (2020)
Clemente Capasso, Jean-Yves Winum
Novel method of treating macular degeneration: a patent evaluation (WO2018/107005). Expert opinion on therapeutic patents 29 (10) (2019)
Jean Jacques Vanden Eynde, Arduino Aleksander Mangoni, Jarkko Rautio, Jérôme Leprince, Yasu-Taka Azuma, Alfonso T García-Sosa, Christopher Hulme, Josef Jampilek, Rafik Karaman, Wei Li, Paula A C Gomes, Dimitra Hadjipavlou-Litina, Raffaele Capasso, Athina Geronikaki, Gennaro Chiappetta, Jean Marc Sabatier, Rino Ragno, Tiziano Tuccinardi, Andrea Trabocchi, Jean-Yves Winum, Francisco Javier Luque, Katalin Prokai-Tatrai, Mariana Spetea, Michael Gütschow, Ivan Kosalec, Catherine Guillou, Maria Helena Vasconcelos, George Kokotos, Giulio Rastelli, Maria Emília Sousa, Clementina Manera, Sandra Gemma, Stefano Mangani, Carlo Siciliano, Stefania Galdieroa, Hong Liu, Peter J H Scott, Cristóbal de Los Ríos, Luigi A Agrofoglio, Simona Collina, Rita C Guedes, Diego Muñoz-Torrero
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6. Molecules (Basel, Switzerland) 25 (1) (2019)
Yassine Aimene, Romain Eychenne, Sonia Mallet-Ladeira, Nathalie Saffon, Jean-Yves Winum, Alessio Nocentini, Claudiu T Supuran, Eric Benoist, Achour Seridi
Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-1,2,3-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis, crystal structure, computational studies and inhibitory activity against carbonic anhydrase I, II, and IX isoforms†. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)
Emma Langella, Vincenzo Alterio, Katia D'Ambrosio, Roberta Cadoni, Jean-Yves Winum, Claudiu T Supuran, Simona Maria Monti, Anna Di Fiore
Exploring benzoxaborole derivatives as carbonic anhydrase inhibitors: a structural and computational analysis reveals their conformational variability as a tool to increase enzyme selectivity. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)
Fabrizio Carta, Pascal Dumy, Claudiu T Supuran, Jean-Yves Winum
Multivalent Carbonic Anhydrases Inhibitors. International journal of molecular sciences 20 (21) (2019)
Marouan Rami, Jean-Yves Winum, Claudiu T Supuran, Patricia Melnyk, Saïd Yous
(Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activators. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)
Ashok Aspatwar, Jean-Yves Winum, Fabrizio Carta, Claudiu T Supuran, Milka Marjut Hammarén, Mataleena Parikka, Seppo Parkkila
Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies. Molecules (Basel, Switzerland) 23 (11) (2018)
Jean-Yves Winum
Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type-2 inflammation: a patent evaluation (WO2017/058370). Expert opinion on therapeutic patents 28 (10) (2018)
Ashok Aspatwar, Holger M Becker, Nanda Kumar Parvathaneni, Milka Hammaren, Aleksandra Svorjova, Harlan Barker, Claudiu T Supuran, Ludwig J Dubois, Philippe Lambin, Mataleena Parikka, Seppo Parkkila, Jean-Yves Winum
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Nasreddine Kanfar, Muhammet Tanc, Pascal Dumy, Claudiu T Supuran, Sébastien Ulrich, Jean-Yves Winum
Effective Access to Multivalent Inhibitors of Carbonic Anhydrases Promoted by Peptide Bioconjugation. Chemistry (Weinheim an der Bergstrasse, Germany) 23 (28) (2017)
Nasreddine Kanfar, Ahmad Mehdi, Pascal Dumy, Sébastien Ulrich, Jean-Yves Winum
Polyhedral Oligomeric Silsesquioxane (POSS) Bearing Glyoxylic Aldehyde as Clickable Platform Towards Multivalent Conjugates. Chemistry (Weinheim an der Bergstrasse, Germany) 23 (71) (2017)

Jean-Yves Winum.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-Yves Winum